Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.350
+0.060 (4.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
Evogene Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 9 | 42 | 26 | 71 | 171 | 39 | |
| Market Cap Growth | -49.08% | 60.63% | -63.17% | -58.36% | 335.98% | -26.91% | |
| Enterprise Value | 6 | 22 | -2 | 20 | 139 | 0 | |
| Last Close Price | 1.35 | 8.40 | 7.00 | 16.40 | 47.00 | 15.20 | |
| PS Ratio | 2.09 | 7.46 | 15.64 | 76.49 | 164.29 | 52.04 | |
| PB Ratio | 1.28 | 1.47 | 0.75 | 1.12 | 3.00 | 0.65 | |
| P/TBV Ratio | - | - | 1.90 | 1.85 | 5.71 | 1.19 | |
| EV/Sales Ratio | 0.81 | 3.96 | - | 22.04 | 133.69 | 0.09 | |
| Debt / Equity Ratio | 0.06 | 0.04 | 0.05 | 0.04 | 0.04 | 0.05 | |
| Asset Turnover | 0.15 | 0.11 | 0.03 | 0.01 | 0.01 | 0.01 | |
| Inventory Turnover | 2.96 | 5.27 | 2.76 | - | - | - | |
| Quick Ratio | 1.03 | 4.57 | 6.41 | 8.00 | 5.21 | 8.37 | |
| Current Ratio | 1.09 | 4.96 | 6.71 | 8.27 | 5.36 | 8.53 | |
| Return on Equity (ROE) | -105.55% | -81.78% | -60.78% | -50.61% | -44.76% | -34.59% | |
| Return on Assets (ROA) | -31.64% | -30.90% | -25.43% | -26.10% | -21.65% | -20.34% | |
| Return on Capital (ROIC) | -61.89% | -49.88% | -32.79% | -30.85% | -25.32% | -23.31% | |
| Earnings Yield | -267.72% | -56.74% | -101.68% | -39.07% | -13.68% | -46.22% | |
| FCF Yield | -236.92% | -53.14% | -94.85% | -35.93% | -11.82% | -47.37% | |
| Buyback Yield / Dilution | -21.07% | -10.86% | -1.92% | -43.59% | -9.34% | -0.00% | |
| Total Shareholder Return | -21.07% | -10.86% | -1.92% | -43.59% | -9.34% | -0.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.